| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-10 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.4 | 5e-09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |